Pseudoephedrine classification OK for pharmacists
Media Release
8 October 2009
Re-classification of pseudoephedrine is business as usual for pharmacists
Following today’s announcement that pseudoephedrine will be reclassified as a prescription-only medicine, the Pharmacy Guild of New Zealand shares the Prime Minister’s commitment to the menace of “P” and understands why he has taken these steps. The Guild says that products containing pseudoephedrine are only a small part of what community pharmacists do and that they will continue to provide good healthy advice to patients and exercise vigilance over a wide range of drugs.
“We hope patients will appreciate that pharmacists will no longer be able to provide pseudoephedrine products without a prescription from their doctor,” says Pharmacy Guild Chief Executive, Annabel Young. “We expect that these changes will create a lot of work for pharmacists.
“The government’s decision to make pseudoephedrine prescription-only has not changed its status as an unsubsidised drug. For that reason pharmacists will not be required to stock and/or supply pseudoephedrine even if the patient has a prescription from a doctor.
“The sales of pseudoephedrine have been declining for some time and it is unclear how the market will react to these changes,” says Ms Young. “Some patients have reported that alternative products containing phenylephrine are not as effective a decongestant as pseudoephedrine but there are mixed views on this.”
ENDS
New Zealand Kindergartens: 100-Years On - Investing In Teacher-Led, Quality Early Childhood Education Is Investing In Aotearoa’s Future
Dry July: Thousands Set To Go Alcohol Free This July As Cancer Diagnoses Continue To Rise Across Aotearoa
New Zealand College of Midwives: Celebrating Midwives Across Aotearoa This International Day Of The Midwife
PPTA Te Wehengarua: Building The Secondary Curriculum On Broken Drafts Is A Serious Risk
Whanganui Regional Museum: Whanganui Makers Bring Textile Traditions To Life During Symposium Weekend
Palmerston North Hospital Foundation: Fundraising For Publicly-Owned Surgical Robot Hits $2 Million Milestone In Less Than Three Months